Jussi Halleen, PhD, Adjunct Professor Chief Executive Officer (CEO), Chairman
Jussi was the founder and CEO for 21 years of a preclinical CRO specialised in oncology and bone diseases. He has developed and patented globally a bone biomarker diagnostic method that received President of Finland’s InnoSuomi award in 2000 and became a commercial success story.
Tiina Kähkönen, PhD Chief Scientific Officer (CSO)
Tiina was a Research Director and CSO in a preclinical CRO. She has led many projects for pharma clients and several EU-funded R&D projects for developing preclinical bone metastasis models. She is a globally acknowledged scientific expert with strong laboratory and technology expertise in bone metastasis models.
Gergana Galabova, DVM, Ph.D. VP Translational Research
Gergana is a Doctor of Veterinary Medicine with over 25 years of experience in preclinical and clinical translational research and development of small molecules and immunotherapies.
Michael Thormann, Ph.D. VP Drug Discovery
Michael holds a Ph.D. in biochemistry and has over 25 years of experience in small-molecule drug discovery, company building and pipeline development as CEO and CSO